In the BioHarmony Drug Report Database

"Preview" Icon

Urokinase

Kinlytic (urokinase) is an enzyme pharmaceutical. Urokinase was first approved as Kinlytic on 1978-01-16. It is used to treat coronary thrombosis, myocardial infarction, pulmonary embolism, vascular graft occlusion, and venous thrombosis in the USA.

 

Trade Name

 

Kinlytic
 

Common Name

 

urokinase
 

ChEMBL ID

 

CHEMBL1201420
 

Indication

 

coronary thrombosis, myocardial infarction, pulmonary embolism, vascular graft occlusion, venous thrombosis
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Urokinase structure rendering